Lipocine Inc (LPCN)

[gi197845]

I agree that it would seem like a run up would be closer to the PDFU date and as that time nears, I don't think the run up will be as much as it was in the past and I would not be surprised if it didn't run up at all.

However, there was some increased volume today, which was good and I wonder why. Obviously, we'd like to see the increased share price remain and increase, if possible.

It appears to me now, that biotechs not only need FDA approval, but sales and revenue growth to increase the share price. In general, it seems like the glory days of biotechs are gone.

I don't think biotechs are like the past glory days, when they would double or triple through each phase I,II and III good results and FDA approval, generally speaking.

Unless, of course, if it was for a life saving block buster drug, that did not have any previous treatments before, in which case, I could see the share price doubling and tripling, before going to market and before revenues.

I hope there isn't dilution or a secondary offering, but I guess I'd take a secondary offering over dilution.

Having said that, I would like to see a buy out offer and in lieu of that, a business partner, I don't think Lipocine can go it alone to bring their meds to market.

Apparently from start to finish, including developing a protocol, patenting it, phase I,II and II trials, along with FDA approval and being on pharmacy shelves, it costs 100 million dollars.

I am not in ATRS at this time, I did want to play both sides, but I went with LPCN.